These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7016305)

  • 1. Standards of care for the patient with "graft-versus-host disease" post bone marrow transplant.
    de la Montaigne M; De Mao J; Nuscher R; Stutzer CA
    Cancer Nurs; 1981 Jun; 4(3):191-8. PubMed ID: 7016305
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchiolitis obliterans in a patient with chronic graft-versus-host disease after bone marrow transplantation].
    Matsumoto K; Yamauchi T; Ichikawa M; Masuda Y; Ogawa K; Arai T; Ito M; Yamashita Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):345-9. PubMed ID: 8778478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of chronic graft-versus-host disease after unrelated-donor bone marrow transplantation. Kanazawa University Bone Marrow Transplant Team].
    Takami A; Nakao S; Ueda M; Takamatsu H; Sugimori N; Yamazaki H; Miura H; Ito K; Yamaguchi M; Niki T
    Rinsho Ketsueki; 1995 Jan; 36(1):6-11. PubMed ID: 7715080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia.
    deMagalhaes-Silverman M; Donnenberg A; Hammert L; Lister J; Myers D; Simpson J; Ball E
    Bone Marrow Transplant; 1997 Jul; 20(2):175-7. PubMed ID: 9244424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant.
    Tai CY; Strande LF; Eydelman R; Sheng X; VanTran JL; Matthews MS; Hewitt CW
    Transplantation; 2004 Jan; 77(2):316-9. PubMed ID: 14743002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K
    Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 gene polymorphism in bone marrow transplant recipients.
    Azarpira N; Ramzi M; Aghdaie MH; Darai M; Geramizadeh B
    Exp Clin Transplant; 2008 Mar; 6(1):74-9. PubMed ID: 18405249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syngeneic graft-versus-host disease: a report of two cases and literature review.
    Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
    Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation.
    Wakui M; Okamoto S; Ishida A; Tanosaki R; Mori T; Kawai Y; Ohshima S; Ikeda Y
    Bone Marrow Transplant; 1996 Oct; 18(4):801-4. PubMed ID: 8899199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
    Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
    Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total nursing care for the bone marrow transplant patient.
    Bourbonnais F; Bédard J
    Can Nurse; 1982 Dec; 78(11):17-21. PubMed ID: 6754068
    [No Abstract]   [Full Text] [Related]  

  • 19. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.
    Byrne JL; Stainer C; Cull G; Haynes AP; Bessell EM; Hale G; Waldmann H; Russell NH
    Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.